Ticovac 2.4MCG/0.5 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTDD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,109
Award facts
- Contract value 100% obligated
- $2,109.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,109.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TICOVAC 2.4MCG/0.5 vaccine units. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain division, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
The parent contract SPE2DR, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. This arrangement authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders spanning multiple therapeutic categories and product lines establishes its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTDD?
SPE2DR26FBTDD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FBTDD worth?
The government has obligated $2,109 on SPE2DR26FBTDD.
Is contract SPE2DR26FBTDD an order under another contract?
Yes. SPE2DR26FBTDD is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTDD competed?
The extent of competition for SPE2DR26FBTDD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award